STRIDE: Semaglutide Shows it Has Legs in Peripheral Artery Disease

[ad_1]

(MedPage Today) — CHICAGO — Semaglutide further solidified its efficacy for diabetes-associated cardiovascular conditions, this time building its positions in peripheral artery disease (PAD) and with an oral formulation, based on two major…

[ad_2]

Source link : https://www.medpagetoday.com/meetingcoverage/acc/114883

Author :

Publish date : 2025-03-29 18:30:00

Copyright for syndicated content belongs to the linked Source.